# The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances

> **NCT02183714** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 146 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** Songha Night ®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02183714
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 1998-12
- **Final completion:** —
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183714, "The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02183714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*